Sam A Pharm Co Stock Cash Flow From Operations
| 009300 Stock | KRW 17,310 240.00 1.37% |
Sam A Pharm Co fundamentals help investors to digest information that contributes to Sam A's financial success or failures. It also enables traders to predict the movement of Sam Stock. The fundamental analysis module provides a way to measure Sam A's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Sam A stock.
Sam |
Sam A Pharm Co Company Cash Flow From Operations Analysis
Sam A's Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.
Current Sam A Cash Flow From Operations | 12.94 B |
Most of Sam A's fundamental indicators, such as Cash Flow From Operations, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Sam A Pharm Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Operating Cash Flow shows the difference between reported income and actual cash flows of the company. If a firm does not have enough cash or cash equivalents to cover its current liabilities, then both investors and management should be concerned about the company having enough liquid resources to meet current and long term debt obligations.
| Competition |
In accordance with the recently published financial statements, Sam A Pharm Co has 12.94 B in Cash Flow From Operations. This is much higher than that of the Healthcare sector and significantly higher than that of the Pharmaceuticals industry. The cash flow from operations for all Republic of Korea stocks is significantly lower than that of the firm.
Sam Cash Flow From Operations Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Sam A's direct or indirect competition against its Cash Flow From Operations to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Sam A could also be used in its relative valuation, which is a method of valuing Sam A by comparing valuation metrics of similar companies.Sam A is currently under evaluation in cash flow from operations category among its peers.
Sam Fundamentals
| Return On Equity | 6.38 | |||
| Return On Asset | 0.0117 | |||
| Profit Margin | 0 % | |||
| Operating Margin | 0.07 % | |||
| Current Valuation | 38.39 B | |||
| Shares Outstanding | 6.1 M | |||
| Shares Owned By Insiders | 65.58 % | |||
| Price To Earning | 14.29 X | |||
| Price To Sales | 1.77 X | |||
| Revenue | 54.67 B | |||
| Gross Profit | 32.37 B | |||
| EBITDA | 7.17 B | |||
| Net Income | 3.39 B | |||
| Cash And Equivalents | 7.98 B | |||
| Total Debt | 1.51 B | |||
| Debt To Equity | 1.70 % | |||
| Current Ratio | 6.57 X | |||
| Cash Flow From Operations | 12.94 B | |||
| Number Of Employees | 287 | |||
| Beta | 0.63 | |||
| Market Capitalization | 108.64 B | |||
| Total Asset | 189.17 B | |||
| Retained Earnings | 122.54 B | |||
| Working Capital | 65.52 B | |||
| Current Asset | 74.43 B | |||
| Current Liabilities | 8.91 B | |||
| Z Score | 42.6 | |||
| Annual Yield | 0.02 % | |||
| Net Asset | 189.17 B |
About Sam A Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Sam A Pharm Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sam A using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sam A Pharm Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Sam A
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Sam A position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sam A will appreciate offsetting losses from the drop in the long position's value.Moving together with Sam Stock
Moving against Sam Stock
The ability to find closely correlated positions to Sam A could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Sam A when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Sam A - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Sam A Pharm Co to buy it.
The correlation of Sam A is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Sam A moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Sam A Pharm moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Sam A can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Sam Stock
Sam A financial ratios help investors to determine whether Sam Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sam with respect to the benefits of owning Sam A security.